PRVA Stock Recent News

Privia Health Group, Inc. (NASDAQ:PRVA ) Q2 2024 Earnings Conference Call August 8, 2024 8:00 AM ET Company Participants Robert Borchert - Senior Vice President, Investor & Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants Josh Raskin - Nephron Research Andrew Mok - Barclays Eduardo Ron - Truist Securities Elizabeth Anderson - Evercore ISI A.J. Rice - UBS Jeff Garro - Stephens Jack Slevin - Jefferies David Larsen - BTIG Richard Close - Canaccord Genuity Jessica Tassan - Piper Sandler Ryan Daniels - William Blair Michael Hall - Baird Ryan Langston - TD Cowen Daniel Grosslight - Citi Adam Ron - Bank of America Operator Hello, and thank you for standing by.

Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago.

ARLINGTON, Va., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the second quarter and six months ended June 30, 2024.

Privia Health (PRVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ARLINGTON, Va., May 30, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its management team plans to present at the 44th Annual William Blair Growth Stock Conference on Wednesday, June 5, 2024, beginning at 11:00 am ET / 10:00 am CT.

Privia Health Group, Inc. (NASDAQ:PRVA ) Q1 2024 Earnings Conference Call May 9, 2024 8:00 AM ET Company Participants Robert Borchert – Senior Vice President-Investor and Corporate Communications Parth Mehrotra – Chief Executive Officer David Mountcastle – Chief Financial Officer Conference Call Participants A.J. Rice – UBS Sameer Patel – Evercore ISI Joshua Raskin – Nephron Research David Larsen – BTIG Richard Close – Canaccord Genuity Andrew Mok – Barclays Jeff Garro – Stephens Jack Slevin – Jefferies Jess Tassan – Piper Sandler Ryan Daniels – William Blair Whit Mayo – Leerink Partners Jailendra Singh – Truist Daniel Grosslight – Citi Adam Ron – Bank of America Operator Welcome to the Privia Health First Quarter 2024 Conference Call.

Privia Health (PRVA) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago.

ARLINGTON, Va., April 09, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for its first quarter ended March 31, 2024 before market open on Thursday, May 9, 2024.

Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.